The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
The farnesoid X receptor (FXR) is a bile acid-regulated nuclear receptor expressed in enterohepatic tissues. In this study we investigated whether FXR is expressed by cells of innate immunity and regulates inflammation in animal models of colitis. Acute (7 days) and chronic (8 wk) colitis were induced in wild-type and FXR−/− mice by intrarectal administration of trinitrobenzensulfonic acid or by 7-day administration of 5% dextran sulfate in drinking water. The results of this experiment demonstrate that FXR is expressed by and exerts counterregulatory effects on cells of innate immunity. Exposure of LPS-activated macrophages to 6-ethyl chenodeoxycholic acid (6E-CDCA; INT-747) a synthetic FXR ligand, results in a reciprocal regulation of NF-κB dependent-genes (TNF-α, IL-1β, IL-6, COX-1, COX-2, and iNOS) and induction of SHP, a FXR-regulated gene. FXR activation stabilizes the nuclear corepressor NCoR on the NF-κB responsive element on the IL-1β promoter. Colon inflammation in Crohn’s disease patients and in rodent models of colitis is associated with a reduced expression of FXR mRNA. Using two rodent models of colon inflammation, we show that progression of these immune-mediated disorders is exacerbated in FXR−/− mice (p < 0.01). In vivo treatment with INT-747 attenuates organ injury and immune cell activation. FXR activation increased the colon expression of I-BABP, FXR, and SHP while reducing IL-1β, IL-2, IL-6, TNF-α, and IFN-γ mRNA expression and attenuating disease severity. In aggregate, these findings provide evidence that FXR is an essential component of a network of nuclear receptors that regulate intestinal innate immunity and homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FXR is implicated in intestinal immunomodulation and barrier function (Vavassori et al., 2009).”
From Bacteroides dorei BDX-01 alleviates DSS-induced experimental colitis in mice by regulating intestinal bile salt hydrolase activity and the FXR-NLRP3 signaling pathway (2023) · cites this paper as Vavassori et al., 2009
In the citing paper
“An additional benefit of FXR activation in the intestine is based on intestinal immunity modulation and decreased ileal bacterial invasion.[80,81]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [80]
In the citing paper
“treatment with a synthetic agonist of BAR has protective effects in mouse models of colitis, whereas BAR-deficient (Nr1h4−/−) mice exhibit exacerbated pathology (Gadaleta et al., 2011; Vavassori et al., 2009).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Vavassori et al., 2009
Citations
Cites
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
The Immunology of Mucosal Models of Inflammation
Strober, W., Fuss, I. J., & Blumberg, R. S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064816 · Cited by 1,304
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,254
Cited by
Items 301–400 of 657
Chen, N., Chan, C. K., Khan, F. U., Makhijani, P., Valentino, T. R., Winer, S., Luk, C. T., & Winer, D. A. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103036 · Cited by 41
Tissue Specific Induction of p62/Sqstm1 by Farnesoid X Receptor
Williams, J. A. R., Thomas, A., Li, G., Kong, B., Zhan, L., Inaba, Y., Xie, W., Ding, W., & Guo, G. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043961 · Cited by 35
Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity
Ranhotra, H. S., Flannigan, K. L., Brave, M., Mukherjee, S., Lukin, D. J., Hirota, S. A., & Mani, S. (2016) · Nuclear Receptor Research · doi:10.11131/2016/101199 · Cited by 39
Lin, Q.-H., Tan, X., Wang, W., Zeng, W., Gui, L., Su, M., Liu, C., Jia, W. P., Xu, L., & Lan, K. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.090464 · Cited by 36
Biagioli, M., & Fiorucci, S. (2021) · Liver Research · doi:10.1016/j.livres.2021.08.003 · Cited by 37
Self-citationTargeting bile acid signaling for the treatment of liver diseases: From bench to bed
Duan, S., Li, X., Fan, G., & Liu, R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113154 · Cited by 33
Yang, Q.-Y., Yang, Y., Tang, Y., Qin, P., Gan, W., Xie, J., Chen, S., Ding, C., Huang, Y., & Zhu, S. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010620 · Cited by 36
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa
Distrutti, E., Santucci, L., Cipriani, S., Renga, B., Schiaroli, E., Ricci, P., Donini, A., & Fiorucci, S. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1041-8 · Cited by 33
Self-citationButyrate Protects against Clostridium difficile Infection by Regulating Bile Acid Metabolism
Wang, S., Xiang, L., Li, F., Deng, W., Lv, P., & Chen, Y. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04479-22 · Cited by 39
Tang, K., Kong, D., Peng, Y., Guo, J., Zhong, Y., Yu, H., Mai, Z., Chen, Y., Chen, Y., Cui, T., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1000444 · Cited by 32
Bile acids, bioactive signalling molecules in interoceptive gut‐to‐brain communication
Joyce, S. A., & O'Malley, D. (2022) · The Journal of Physiology · doi:10.1113/jp281727 · Cited by 36
Cao, L., Qin, R., & Liu, J. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110080 · Cited by 30
Missailidis, C., Neogi, U., Stenvinkel, P., Trøseid, M., Nowak, P., & Bergman, P. (2018) · AIDS · doi:10.1097/qad.0000000000001813 · Cited by 31
Francis, M., Guo, G. L., Kong, B., Абрамова, Е. В., Cervelli, J. A., Gow, A. J., Laskin, J. D., & Laskin, D. L. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa111 · Cited by 31
Role of Farnesoid X Receptor in the Pathogenesis of Respiratory Diseases
Wu, J., Chen, J., & Chen, J. (2020) · Canadian Respiratory Journal · doi:10.1155/2020/9137251 · Cited by 38
Jung, H.-K., Chen, J., Hu, X., Sun, H., Wu, S.-Y., Chiang, C., KEMPER, B. W., Chen, L., & Kemper, J. K. (2020) · JCI Insight · doi:10.1172/jci.insight.141640 · Cited by 32
Fiorucci, S., Biagioli, M., Baldoni, M., Ricci, P., Sepe, V., Zampella, A., & Distrutti, E. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1916465 · Cited by 30
Self-citationRuiz, A., Andree, K. B., Furones, D., Holhorea, P. G., Calduch-Giner, J. À., Viñas, M., Pérez‐Sánchez, J., & Gisbert, E. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1123716 · Cited by 34
Porez, G., Gross, B. S., Prawitt, J., Gheeraert, C., Berrabah, W., Alexandre, J., Staels, B., & Lefèbvre, P. (2013) · Endocrinology · doi:10.1210/en.2013-1263 · Cited by 37
Smith, D. L. H., Keshavan, P., Avissar, U., Ahmed, K., & Zucker, S. D. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq050 · Cited by 32
Pleiotropic roles of FXR in liver and colorectal cancers
Huang, X., Fan, M., & Huang, W. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111543 · Cited by 33
Michaels, M., & Madsen, K. L. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2022.11.001 · Cited by 36
Interkingdom signaling between gastrointestinal hormones and the gut microbiome
Zhao, X., Qiu, Y., Liang, L., & Fu, X. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2456592 · Cited by 34
Moran, C. P., Sheehan, D., & Shanahan, F. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000157 · Cited by 32
Jia, L., Jiang, D., Hu, P., Li, X., Shi, H., Cheng, D., & Zhang, L. (2014) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2014.03.016 · Cited by 32
The Link Between the Microbiota and HER2+ Breast Cancer: The New Challenge of Precision Medicine
Modica, M. D., Arlotta, V., Sfondrini, L., Tagliabue, E., & Triulzi, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.947188 · Cited by 36
Jin, W., Jiang, L., Hu, S., & Zhu, A. (2022) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2022.109496 · Cited by 37
Intestinal Barrier, Immunity and Microbiome: Partners in the Depression Crime
Medina-Rodriguez, E. M., Martínez-Raga, J., & Sanz, Y. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.001202 · Cited by 34
Insights into the Mechanisms That May Clarify Obesity as a Risk Factor for Multiple Sclerosis
Huitema, M. J. D., & Schenk, G. J. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0827-5 · Cited by 34
Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic Disease
van Zutphen, T., Bertolini, A., de Vries, H. D., Bloks, V. W., de Boer, J. F., Jonker, J. W., & Kuipers, F. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_233 · Cited by 33
Wang, X., Niu, Y., Yue, C.-X., Fu, S., & Wang, R. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.10.002 · Cited by 29
Epithelial sensing of microbiota-derived signals
Eshleman, E. M., & Alenghat, T. (2021) · Genes and Immunity · doi:10.1038/s41435-021-00124-w · Cited by 37
Bijsmans, I. T. G. W., Guercini, C., Pittol, J. M. R., Omta, W. A., Milona, A., Lelieveld, D., Egan, D. A., Pellicciari, R., Gioiello, A., & van Mil, S. W. C. (2015) · Scientific Reports · doi:10.1038/srep14086 · Cited by 35
Lajczak, N., Saint‐Criq, V., O’Dwyer, A. M., Perino, A., Adorini, L., Schoonjans, K., & Keely, S. J. (2017) · The FASEB Journal · doi:10.1096/fj.201601365r · Cited by 34
Kisthardt, S. C., Thanissery, R., Pike, C. M., Foley, M. H., & Theriot, C. M. (2023) · Journal of Bacteriology · doi:10.1128/jb.00180-23 · Cited by 31
Chen, P., Wu, Z., Cui, Z., Liu, C., Lei, K., Tian, S., Mai, K., & Zhang, W. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.109114 · Cited by 31
Marchianò, S., Biagioli, M., Bordoni, M., Morretta, E., Giorgio, C. D., Vellecco, V., Roselli, R., Bellini, R., Massa, C., Cari, L., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.031241 · Cited by 31
Self-citationGao, Y., Zhao, Y., Yuan, A., Xu, L., Huang, X., Su, Y., Gao, L., Ji, Q., Pu, J., & He, B. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.07.004 · Cited by 28
Bessonneau, V., Gerona, R. R. L., Trowbridge, J., Grashow, R. G., Lin, T. S., Buren, H., Morello-Frosch, R. A., & Rudel, R. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-87070-9 · Cited by 30
Zhang, J., Gao, L.-Z., Chen, Y.-J., Zhu, P.-P., Yin, S.-S., Su, M., Ni, Y., Miao, J., Wu, W.-L., Chen, H., et al. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.085670 · Cited by 32
Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease
Ning, L., Lou, X., Zhang, F., & Xu, G. (2019) · Mediators of Inflammation · doi:10.1155/2019/2624941 · Cited by 28
Carcinogenic and anticancer activities of microbiota-derived secondary bile acids
Kouhzad, M., Götz, F., Navidifar, T., Taki, E., Ghamari, M., Mohammadzadeh, R., Seyedolmohadesin, M., & Bostanghadiri, N. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1514872 · Cited by 34
A CK2–RNF4 interplay coordinates non-canonical SUMOylation and degradation of nuclear receptor FXR
Bilodeau, S., Caron, V., Gagnon, J., Kuftedjian, A., & Tremblay, A. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx009 · Cited by 29
Fernández-Murga, M. L., Petrov, P., Conde, I., Castell, J. V., Gómez‐Lechón, M. J., & Jover, R. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.07.017 · Cited by 32
Bradley, R. D., Langley, B. O., Ryan, J. J., Phipps, J. C., Hanes, D. A., Stack, E. H., Jansson, J. K., Metz, T., & Stevens, J. F. (2020) · Trials · doi:10.1186/s13063-020-04769-2 · Cited by 32
Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis
Lian, F., WANG, Y., Xiao, Y., Wu, X., Xu, H., Liang, L., & Yang, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4159 · Cited by 28
Bile acids and their receptors in hepatic immunity
Fiorucci, S., Marchianò, S., Distrutti, E., & Biagioli, M. (2025) · Liver Research · doi:10.1016/j.livres.2025.01.005 · Cited by 31
Self-citationRzeczycki, P., Pęciak, O., Plust, M., & Droździk, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411897 · Cited by 30
van Schaik, F. D. M., Gadaleta, R. M., Schaap, F. G., van Mil, S. W. C., Siersema, P. D., Oldenburg, B., & van Erpecum, K. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049706 · Cited by 25
Bile acids and FXR in functional gastrointestinal disorders
Mosińska, P., Szczepaniak, A., & Fichna, J. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.05.016 · Cited by 33
Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis
Ding, C., Wang, Z., Dou, X., Yang, Q., Ning, Y., Kao, S., Sang, X., Hao, M., Wang, K., Peng, M., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0830 · Cited by 43
Lin, S., Wang, T., Xu, H., Zhang, X.-N., Wang, Q., Liu, R., Li, Q., & Kai-shun, B. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.04.009 · Cited by 29
Intestinal Dysbiosis and Autoimmune Pancreatitis
Yoshikawa, T., Watanabe, T., Kamata, K., Hara, A., Minaga, K., & Kudo, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.621532 · Cited by 27
Yan, M., Hou, L., Cai, Y., Wang, H., Ma, Y., Geng, Q., Jiang, W., & Tang, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.906452 · Cited by 30
Microbial metabolites and immunotherapy: Basic rationale and clinical indications
Kovtonyuk, L. V., & McCoy, K. D. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101755 · Cited by 27
Guthrie, G. J., Tackett, B. C., Stoll, B., Martin, C. R., Olutoye, O. O., & Burrin, D. G. (2017) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607117722752 · Cited by 27
Thompson, B. A., Lu, S., Revilla, J., Uddin, M. J., Oakland, D. N., Brovero, S. G., Keleş, S., Bresnick, E. H., Petri, W. A., & Burgess, S. L. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022009618 · Cited by 31
Thangamani, S., Monasky, R. C., Lee, J. K., Antharam, V. C., HogenEsch, H., Hazbun, T. R., Jin, Y., Gu, H., & Guo, G. L. (2021) · Journal of Fungi · doi:10.3390/jof7121030 · Cited by 26
Bile acid–gut microbiota crosstalk in irritable bowel syndrome
Gu, Y., Li, L., Yang, M., Liu, T., Song, X., Qin, X., Xu, X. J., Liu, J., Wang, B., & Cao, H. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2058353 · Cited by 29
Zweers, S. J. L. B., de Vries, E. M., Leníček, M., Tolenaars, D., de Waart, D. R., Koelfat, K. V. K., Groen, A. K., Damink, S. W. M. O., Beuers, U. H., Ponsioen, C. Y., et al. (2016) · Hepatology International · doi:10.1007/s12072-016-9769-7 · Cited by 27
Ipharraguerre, I. R., Pastor, J. J., Gavaldà‐Navarro, A., Villarroya, F., & Mereu, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-32107-9 · Cited by 29
Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts
Özdirik, B., & Schnabl, B. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.12.005 · Cited by 27
Urbani, G., Rondini, E., Distrutti, E., Marchianò, S., Biagioli, M., & Fiorucci, S. (2025) · Cells · doi:10.3390/cells14080595 · Cited by 28
Self-citationTargeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects
Gangwar, S. K., Kumar, A., Yap, K. C.-H., Jose, S., Parama, D., Sethi, G., Kumar, A. P., & Kunnumakkara, A. B. (2022) · Pharmaceuticals · doi:10.3390/ph15050624 · Cited by 23
Goyal, N. P., Rana, A., Bijjem, K. R. V., & Kumar, P. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.12.018 · Cited by 23
Nolan, J., Johnston, I. M., & Walters, J. R. F. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.12.66 · Cited by 25
Farnesoid X receptor as a regulator of fuel consumption and mitochondrial function
Han, C. Y., Kim, T. H., Koo, J. H., & Kim, S. G. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0812-y · Cited by 25
Negroni, A., Fiaschini, N., Palone, F., Vitali, R., Colantoni, E., Laudadio, I., Oliva, S., Aloi, M., Cucchiara, S., & Stronati, L. (2020) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002759 · Cited by 26
Aberrant Gut-To-Brain Signaling in Irritable Bowel Syndrome - The Role of Bile Acids
Dhonnabháín, R. N., Xiao, Q., & O’Malley, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.745190 · Cited by 28
Deciphering the role of gut metabolites in non-alcoholic fatty liver disease
Ralli, T., Saifi, Z., Tyagi, N., Vidyadhari, A., Aeri, V., & Kohli, K. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2142091 · Cited by 23
Emerging roles of host and microbial bioactive lipids in inflammatory bowel diseases
Kayama, H., & Takeda, K. (2023) · European Journal of Immunology · doi:10.1002/eji.202249866 · Cited by 22
Wang, B., Han, D. W., Hu, X., Chen, J., Liu, Y., & Wu, J. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127865 · Cited by 25
Gray, D. W., Welsh, M. D., Doherty, S., Mansoor, F., Chevallier, O. P., Elliott, C. T., & Mooney, M. H. (2015) · Veterinary Research · doi:10.1186/s13567-014-0138-z · Cited by 27
Bile acid metabolism is altered in those with insulin resistance after gestational diabetes mellitus
Maghsoodi, N., Shaw, N., Cross, G. F., Alaghband‐Zadeh, J., Wierzbicki, A. S., Pinkney, J. H., Millward, A., & Vincent, R. P. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.11.016 · Cited by 25
Fiorucci, S., Urbani, G., Giorgio, C. D., Biagioli, M., & Distrutti, E. (2024) · Cells · doi:10.3390/cells13191650 · Cited by 26
Self-citationTawfiq, R. A., Nassar, N. N., Hammam, O. A., Allam, R. M., Elmazar, M. M., Abdallah, D. M., & Attia, Y. M. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109953 · Cited by 21
Lin, Q., Huang, W.-W., Shen, W., Deng, X., Tang, Z., Chen, Z., Zhao, W., & Fan, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.889646 · Cited by 25
Dysbiosis: The first hit for digestive system cancer
Mei, S., Deng, Z., Chen, Y., Ning, D.-M., Guo, Y., Fan, X., Wang, R., Meng, Y., Zhou, Q., & Tian, X. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1040991 · Cited by 24
Proteome Profiling in Lung Injury Following Hematopoietic Stem Cell Transplantation
Bhargava, M., Viken, K., Dey, S., Steinbach, M. S., Wu, B.-L., Jagtap, P., Higgins, L., Panoskaltsis-Mortari, A., Weisdorf, D., Kumar, V., et al. (2016) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2016.04.021 · Cited by 18
Intestinal failure to produce FGF19: A culprit in intestinal failure–associated liver disease?
van Erpecum, K. J., & Schaap, F. G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.012 · Cited by 22
Aldriwesh, M. G., Alotibi, R. S., Alqurainy, N., Alrabiah, S., Arafah, A. M., Alghoribi, M. F., & Ajina, R. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2607076 · Cited by 24
Zhu, Y., Xu, S., Lu, Y., Wei, Y., Yao, B., Guo, F., Zheng, X., Wang, Y., He, Y., Jin, L., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00590 · Cited by 21
Regional specialization of macrophages along the gastrointestinal tract
Berthold, D. L., Jones, K. D. J., & Udalova, I. A. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.07.006 · Cited by 22
Li, Y., Wang, K., Ding, J., Sun, S., Ni, Z., & Yu, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.954684 · Cited by 23
Patel, D., Evanchuk, J. L., Wang, R., Dunbar, C. L., Munhoz, J., & Field, C. J. (2023) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2022-0456 · Cited by 20
Targeting Farnesoid X Receptor in Tumor and the Tumor Microenvironment: Implication for Therapy
Nenkov, M., Shi, Y. H., Ma, Y., Gaßler, N., & Chen, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010006 · Cited by 24
Misawa, T., Hayashi, H., Sugiyama, Y., & Hashimoto, Y. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.016 · Cited by 20
Mališová, L., Kováčová, Z., Koc, M., Kračmerová, J., Štich, V., & Rossmeislová, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082086 · Cited by 22
Use of Farnesoid X Receptor Agonists to Treat Nonalcoholic Fatty Liver Disease
Sanyal, A. J. (2015) · Digestive Diseases · doi:10.1159/000371698 · Cited by 20
Qian, S., Su, Z., Lin, J., Hou, Q., Wang, X., Li, Y., Wang, J., Huang, C., Wang, Z., Cubero, F. J., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02224-w · Cited by 24
“FXR remains a key component of the nuclear receptor network that regulates intestinal innate immunity and homeostasis in animal models of colitis [18].”
Bile acid‐activated receptors in innate and adaptive immunity: targeted drugs and biological agents
Cheung, K. C. P., Ma, J., Loiola, R. A., Chen, X., & Jia, W. P. (2023) · European Journal of Immunology · doi:10.1002/eji.202250299 · Cited by 24
Effects of bile acid metabolism on intestinal health of livestock and poultry
Jia, H., & Dong, N. (2024) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.13969 · Cited by 21
Roles of Bile Acid-Activated Receptors in Monocytes-Macrophages and Dendritic Cells
Jia, H., He, X., Jiang, T., & Kong, F. (2025) · Cells · doi:10.3390/cells14120920 · Cited by 22
Buchynskyi, M., Kamyshna, I. I., Oksenych, V., Zavidniuk, N. H., & Kamyshnyi, O. (2023) · Viruses · doi:10.3390/v15051072 · Cited by 18
Dai, M., Wan, P., Lin, L., Wu, Z. E., Zhang, T., Zhao, Q., Cheng, Y., Lin, Q., Zhang, B., Liu, A., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155054 · Cited by 20
Bile acids and bile acid activated receptors in the treatment of Covid-19
Fiorucci, S., Urbani, G., Biagioli, M., Sepe, V., Distrutti, E., & Zampella, A. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115983 · Cited by 18
Self-citationRenga, B., D’Amore, C., Cipriani, S., Mencarelli, A., Carino, A., Sepe, V., Zampella, A., Distrutti, E., & Fiorucci, S. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.08.008 · Cited by 22
Self-citationBile Acids and Portal Hypertension
Arab, J. P., Francisco Barrera, M., & Arrese, M. A. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.5500 · Cited by 19
Impaired Bile Secretion Promotes Hepatobiliary Injury in Sickle Cell Disease
Vats, R., Liu, S., Zhu, J., Mukhi, D., Tütüncüoğlu, E., Cárdenes, N., Singh, S., Brzóska, T., Kosar, K., Bamne, M. N., et al. (2020) · Hepatology · doi:10.1002/hep.31239 · Cited by 22
Molecular and metabolomic changes in the proximal colon of pigs infected with Trichuris suis
Dawson, H. D., Chen, C. T., Li, R. W., Bell, L. N., Shea‐Donohue, T., Kringel, H., Beshah, E., Hill, D. E., & Urban, J. F. (2020) · Scientific Reports · doi:10.1038/s41598-020-69462-5 · Cited by 19
Metadata
- Authors
- Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S.
- Affiliations
- University of Perugia (IT)
- Azienda Ospedaliera di Perugia (IT)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11
- Volume
- 183
- Issue
- 10
- Pages
- 6251-6261
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2125524268
- Cited by
- 655
- References
- 34
- Citations by year
- 2026: 42 · 2025: 51 · 2024: 49 · 2023: 52 · 2022: 71 · 2021: 56 · 2020: 55 · 2019: 40 · 2018: 34 · 2017: 36 · 2016: 31 · 2015: 31 · 2014: 25 · 2013: 22 · 2012: 25
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- farnesoid X receptor, intestinal innate immunity, colitis, Crohn's disease, NF-κB, SHP, NCoR, macrophages, chenodeoxycholic acid, trinitrobenzene sulfonic acid, dextran sulfate, TNF-α, IL-1β, interleukin-6, intestinal inflammation, nuclear receptors, intestinal homeostasis
- MeSH terms
- Receptor, Farnesoid X-Activated, Acute Disease, Adult, Animals, Chronic Disease, Colitis, Crohn Disease, Female, Humans, Immunity, Innate, Intestinal Mucosa, Intestines, Lipopolysaccharides, Macrophages, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Trinitrobenzenesulfonic Acid, NF-kappa B, Mice, SCID, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Mice, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.